You are here:

Forthcoming Submissions:

PACE medicines

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due

Non-PACE medicines

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due
empaglifozin linagliptin fixed-dose combination (Glyxambi) Boehringer Ingelheim Ltd Abbreviated Submission N/A 4/04/2017 8/05/2017
insulin aspart (Faster Aspart) Novo Nordisk Ltd Abbreviated Submission N/A 7/03/2017 10/04/2017
micronised progesterone (Utrogestan) Besins Healthcare (UK) Ltd Full submission 6/03/2017 4/04/2017 8/05/2017
saxagliptin - dapagliflozin (Qtern) AstraZeneca UK Ltd Abbreviated Submission N/A 6/06/2017 10/07/2017

Medicines with advice withheld pending product availability

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due

Back